Last reviewed · How we verify
NCT03243045
Systemic Microvascular Function in Patients With Resistant Hypertension After Renal Sympathetic Denervation
trial testing Renal sympathetic denervation in Arterial Hypertension in 20 participants. Completed in 6 January 2020.
6 January 2020
Quick facts
| Lead sponsor | National Institute of Cardiology, Laranjeiras, Brazil |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 1 March 2017 |
| Primary completion | 6 January 2020 |
| Estimated completion | 6 January 2020 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Renal sympathetic denervation
Conditions studied
- Arterial Hypertension — all drugs for Arterial Hypertension →
- Resistant Arterial Hypertension — all drugs for Resistant Arterial Hypertension →
Sponsor
National Institute of Cardiology, Laranjeiras, Brazil
Who can join
Adults 18 to 80, any sex, with Arterial Hypertension or Resistant Arterial Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It has been proposed that the modulation of the activity of the sympathetic nervous system, through renal sympathetic denervation, besides reducing blood pressure, would promote an improvement in vascular reactivity and consequent improvement of macro and microcirculation. The present study aimed to investigate the influence of the renal sympathetic denervation on the skin microvascular function of patients presenting with resistant arterial hypertension.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03243045
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Renal sympathetic denervation
Trials testing the same drug.
- NCT06845579 — Prediction of Blood Pressure Outcomes Following Renal Denervation (PREDICT-RDN) · NA · recruiting
Other recruiting trials for Arterial Hypertension
Currently open trials in the same condition.
- NCT06769269 — Hypertension Registry: Study of Primary and Secondary Hypertension Phenotypes, Complications, and Treatment Personalizat · recruiting
- NCT07303556 — Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs · NA · active not recruiting
- NCT06828211 — Trans-resveratrol's Influence on the Development of CHF in Early Postmenopausal Women with HTN and Reduced BMD · NA · active not recruiting
- NCT07049289 — Telemonitoring in Arterial Hypertension · NA · active not recruiting
- NCT06722625 — Telemedical Algorithm-Supported Care for Hypertension · NA · recruiting
Other National Institute of Cardiology, Laranjeiras, Brazil trials
Trials by the same sponsor.
- NCT05728047 — Evaluation of Systemic Microcirculation of Patients Undergoing Heart Valve Surgery · completed
- NCT04946396 — Effects of Continuous Dexmedetomidine Infusion on Systemic Microvascular Function in Laparoscopic Cholecystecthomy · NA · completed
- NCT05464849 — Evaluation of Systemic Microvascular Reactivity in Patients With Resistant Hypertension · completed
- NCT05864729 — The Association Between Systemic Microvascular Endothelial Function and Coronary Physiology Indexes · NA · completed
- NCT04406545 — Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19. · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03243045 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute of Cardiology, Laranjeiras, Brazil
- Last refreshed: 7 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03243045.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing